Testosterone Side Effects in Women: What to Watch
SaveTestosterone in women can cause androgenic side effects — acne, oily skin, and increased facial or body hair — that are usually dose-related and often reversible. Higher, supraphysiologic doses raise the chance of voice changes and other lasting effects. The one evidence-based use is low desire after menopause [1].
Last updated: July 2026
Why do some women take testosterone at all?
Testosterone is present in women at levels roughly 10 to 20 times lower than in men, and it drifts down gradually with age rather than dropping sharply at menopause. In the United States no testosterone product is approved specifically for women, so it is prescribed off-label. According to the 2019 global consensus statement endorsed by the Endocrine Society and the International Menopause Society, the single evidence-based indication is hypoactive sexual desire disorder in postmenopausal women — persistent low desire that causes distress 1Ref 1Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019).Global Consensus Position Statement on the Use of Testosterone Therapy for Women.The one evidence-based indication (postmenopausal hypoactive sexual desire disorder), the dose-related nature of androgenic side effects, the risk of virilization when levels exceed the premenopausal range, the recommendation against pellets and injectable testosterone, and the need to keep and monitor blood levels within the female physiologic range.. Concerns like this are assessed within the wider frame of female sexual function and relationships 2Ref 2American College of Obstetricians and Gynecologists (2019).Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213.Framing of low sexual desire and female sexual dysfunction as a whole-picture assessment within which off-label testosterone is sometimes considered.. Even then, the desire benefit is modest, and it sits alongside other approaches to low sexual desire and to menopause treatment.
What androgenic side effects should you watch for?
Acne, oily skin, and increased facial or body hair are the most common side effects of testosterone in women, and they track closely with dose 1Ref 1Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019).Global Consensus Position Statement on the Use of Testosterone Therapy for Women.The one evidence-based indication (postmenopausal hypoactive sexual desire disorder), the dose-related nature of androgenic side effects, the risk of virilization when levels exceed the premenopausal range, the recommendation against pellets and injectable testosterone, and the need to keep and monitor blood levels within the female physiologic range.. The Endocrine Society's hirsutism guidance describes how excess androgen drives coarse, dark hair growth in a male-like pattern across the face, chest, and abdomen 3Ref 3Martin KA, et al. (Endocrine Society) (2018).Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline.How excess androgen drives coarse hair growth in a male-like pattern, and that high androgen signs in reproductive-age women more often reflect an underlying disorder such as PCOS.. In trials using physiologic doses — levels kept within the normal premenopausal range — acne and unwanted hair were only slightly more common than with placebo, bothering fewer than 1 in 10 women 1Ref 1Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019).Global Consensus Position Statement on the Use of Testosterone Therapy for Women.The one evidence-based indication (postmenopausal hypoactive sexual desire disorder), the dose-related nature of androgenic side effects, the risk of virilization when levels exceed the premenopausal range, the recommendation against pellets and injectable testosterone, and the need to keep and monitor blood levels within the female physiologic range.. Most changes are mild and tend to ease within about 3 to 6 months when the dose is reduced. Scalp thinning can also occur, echoing the pattern behind some menopausal hair changes.
Which changes can become permanent?
A handful of masculinizing changes can persist even after testosterone is stopped, which is why higher doses carry greater stakes. Voice deepening, clitoral enlargement, and male-pattern scalp hair loss are the effects most likely to become permanent, whereas acne and mild extra hair usually reverse once the dose comes down 1Ref 1Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019).Global Consensus Position Statement on the Use of Testosterone Therapy for Women.The one evidence-based indication (postmenopausal hypoactive sexual desire disorder), the dose-related nature of androgenic side effects, the risk of virilization when levels exceed the premenopausal range, the recommendation against pellets and injectable testosterone, and the need to keep and monitor blood levels within the female physiologic range.. These lasting changes, grouped together as virilization, become far more likely when blood testosterone climbs well above the normal premenopausal range 1Ref 1Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019).Global Consensus Position Statement on the Use of Testosterone Therapy for Women.The one evidence-based indication (postmenopausal hypoactive sexual desire disorder), the dose-related nature of androgenic side effects, the risk of virilization when levels exceed the premenopausal range, the recommendation against pellets and injectable testosterone, and the need to keep and monitor blood levels within the female physiologic range.. Virilization is uncommon at carefully monitored physiologic doses, according to the 2019 consensus statement, which recommends against any regimen that pushes levels into the male range 1Ref 1Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019).Global Consensus Position Statement on the Use of Testosterone Therapy for Women.The one evidence-based indication (postmenopausal hypoactive sexual desire disorder), the dose-related nature of androgenic side effects, the risk of virilization when levels exceed the premenopausal range, the recommendation against pellets and injectable testosterone, and the need to keep and monitor blood levels within the female physiologic range.. Trial safety data extend to only about 24 months, so effects beyond that are less certain 1Ref 1Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019).Global Consensus Position Statement on the Use of Testosterone Therapy for Women.The one evidence-based indication (postmenopausal hypoactive sexual desire disorder), the dose-related nature of androgenic side effects, the risk of virilization when levels exceed the premenopausal range, the recommendation against pellets and injectable testosterone, and the need to keep and monitor blood levels within the female physiologic range.. Noticing a deepening voice or new coarse hair early gives the best chance to adjust before changes set in.
Why does dosing and delivery route matter so much?
Side-effect risk rises steeply when blood testosterone moves above the premenopausal range, so how a dose is delivered matters as much as the amount. Compounded pellets implanted under the skin and high-dose injections are the routes most likely to produce supraphysiologic peaks, and the 2019 global consensus recommends against pellets and injectable testosterone for this reason 1Ref 1Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019).Global Consensus Position Statement on the Use of Testosterone Therapy for Women.The one evidence-based indication (postmenopausal hypoactive sexual desire disorder), the dose-related nature of androgenic side effects, the risk of virilization when levels exceed the premenopausal range, the recommendation against pellets and injectable testosterone, and the need to keep and monitor blood levels within the female physiologic range.. Transdermal creams or gels formulated for the female range allow steadier, lower levels and easier adjustment 1Ref 1Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019).Global Consensus Position Statement on the Use of Testosterone Therapy for Women.The one evidence-based indication (postmenopausal hypoactive sexual desire disorder), the dose-related nature of androgenic side effects, the risk of virilization when levels exceed the premenopausal range, the recommendation against pellets and injectable testosterone, and the need to keep and monitor blood levels within the female physiologic range.. Life stage shapes the picture too: in the reproductive years, high androgen signs more often point to PCOS than to treatment, while after menopause low desire is the usual reason testosterone is weighed 3Ref 3Martin KA, et al. (Endocrine Society) (2018).Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline.How excess androgen drives coarse hair growth in a male-like pattern, and that high androgen signs in reproductive-age women more often reflect an underlying disorder such as PCOS.. Baseline and follow-up blood levels help keep therapy in the safe range.
When testosterone side effects need a clinician
A clinician experienced in menopause or hormonal health can weigh whether testosterone is reasonable for you, check baseline and periodic blood levels, and match the dose and route to keep androgenic effects unlikely. According to the 2019 consensus statement, monitoring blood testosterone every 3 to 6 months early on helps catch levels creeping above the female range before side effects appear 1Ref 1Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019).Global Consensus Position Statement on the Use of Testosterone Therapy for Women.The one evidence-based indication (postmenopausal hypoactive sexual desire disorder), the dose-related nature of androgenic side effects, the risk of virilization when levels exceed the premenopausal range, the recommendation against pellets and injectable testosterone, and the need to keep and monitor blood levels within the female physiologic range.. Someone with new acne, unwanted hair, or a voice change on therapy has a clear reason to revisit the plan. Gale can help you prepare for that conversation with the right questions and history in hand.
Common questions
Related
Menopause & midlife
Hormone Pellets: Why Guidelines Urge CautionMenopause & midlife
Testosterone for Women: The Libido EvidenceMenopause & midlife
HRT and Libido: Helpful, But Not a Switch
Say it back
How would you explain this to someone you love?
Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.
When to check in about testosterone
- —A deepening or hoarse voice, or new male-pattern scalp hair loss, while on testosterone is a reason to seek prompt clinician review.
- —Rapidly worsening acne or fast-spreading facial or body hair is a reason to have your dose and blood levels rechecked.
- —Clitoral enlargement or other genital changes is a reason to seek clinician review before continuing.
- —Blood testosterone measured above the normal premenopausal range is a reason to review the dose and delivery route with your prescriber.
This article is general health education, not medical advice. Whether testosterone is appropriate, and at what dose and route, is a decision to make with a clinician experienced in menopause or hormonal health who knows your full history.
References
- 1.Davis SR, et al. (International consensus, endorsed by The Endocrine Society and International Menopause Society) (2019). Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Journal of Clinical Endocrinology & Metabolism. doi:10.1210/jc.2019-01603 ✓The one evidence-based indication (postmenopausal hypoactive sexual desire disorder), the dose-related nature of androgenic side effects, the risk of virilization when levels exceed the premenopausal range, the recommendation against pellets and injectable testosterone, and the need to keep and monitor blood levels within the female physiologic range.
- 2.American College of Obstetricians and Gynecologists (2019). Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000003324 ✓Framing of low sexual desire and female sexual dysfunction as a whole-picture assessment within which off-label testosterone is sometimes considered.
- 3.Martin KA, et al. (Endocrine Society) (2018). Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. doi:10.1210/jc.2018-00241 ✓How excess androgen drives coarse hair growth in a male-like pattern, and that high androgen signs in reproductive-age women more often reflect an underlying disorder such as PCOS.
3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy